GENFIT S.A. American Depositary Shares

GNFT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
GNFT Income Statement
GNFT Balance Sheet
GNFT Cash Flow
Congress Trading

Recent trades of GNFT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GNFT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
GNFT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GNFT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by GNFT's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Non-invasive diagnostic of non-alcoholic steatohepatitis Oct. 01, 2024
  • Patent Title: Pharmaceutical compositions for combination therapy Aug. 06, 2024
  • Patent Title: Methods of treatment of cholestatic diseases Aug. 06, 2024
  • Patent Title: Elafibranor salts Jul. 09, 2024
  • Patent Title: Rorgamma modulators and uses thereof May. 07, 2024
  • Patent Title: Methods of treatment of cholestatic diseases Jan. 02, 2024
  • Patent Title: Methods of treatment of cholestatic diseases Dec. 26, 2023
  • Patent Title: Automated pattern recognition and scoring method of histological images Jun. 13, 2023
  • Patent Title: Pharmaceutical compositions for combination therapy Feb. 28, 2023
  • Patent Title: Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis Dec. 06, 2022
  • Patent Title: Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor Nov. 01, 2022
  • Patent Title: Combination of elafibranor or derivatives thereof with an anti-nash, anti-fibrotic or anti-cholestatic agent Oct. 25, 2022
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Aug. 02, 2022
  • Patent Title: Methods for diagnosing and evaluating non-alcoholic steatohepatitis Jun. 28, 2022
  • Patent Title: Methods of treatment of cholestatic diseases May. 17, 2022
  • Patent Title: Pharmaceutical compositions for combination therapy Dec. 07, 2021
  • Patent Title: Methods of treatment of cholestatic diseases Nov. 30, 2021
  • Patent Title: Rorgamma modulators and uses thereof Nov. 02, 2021
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Aug. 31, 2021
  • Patent Title: Rorgamma modulators and uses thereof Aug. 03, 2021
  • Patent Title: N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2h-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ror-gamma modulators for treating autoimmune diseases Jul. 06, 2021
  • Patent Title: Pharmaceutical compositions for combination therapy Jun. 15, 2021
  • Patent Title: Rorgamma modulators and uses thereof Apr. 27, 2021
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Feb. 02, 2021
  • Patent Title: Derivatives of 6-substituted triazolopyridazines as rev-erb agonists Oct. 13, 2020
  • Patent Title: Methods of treatment of fibrosis and cancers Oct. 06, 2020
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 28, 2020
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases May. 19, 2020
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 16, 2019
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 20, 2018
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 20, 2018
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 06, 2018
  • Patent Title: Methods of treatment for cholestatic and fibrotic diseases Nov. 06, 2018
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 17, 2018
  • Patent Title: Heterocyclic derivatives as rorgamma modulators Feb. 27, 2018
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Oct. 10, 2017
  • Patent Title: Derivatives of 6-substituted triazolopyridazines as rev-erb agonists Mar. 07, 2017
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Mar. 07, 2017
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Dec. 29, 2015
  • Patent Title: 1,3-diphenylpropane derivatives, preparations and uses thereof Aug. 25, 2015
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Nov. 25, 2014
  • Patent Title: Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Jul. 08, 2014
  • Patent Title: Preparation of chalcone derivatives Jul. 01, 2014
  • Patent Title: Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Jun. 11, 2013
  • Patent Title: Ppar agonist compounds, preparation and uses Jun. 11, 2013
  • Patent Title: Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof Sep. 04, 2012
  • Patent Title: Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof May. 29, 2012
  • Patent Title: Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Jan. 31, 2012
  • Patent Title: Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof Nov. 15, 2011
  • Patent Title: Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof May. 17, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of GNFT in WallStreetBets Daily Discussion

GNFT News

Recent insights relating to GNFT

CNBC Recommendations

Recent picks made for GNFT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GNFT

GNFT Top Shareholders
Shareholder
Shares Held
GNFT Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GNFT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GNFT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top